About this trial
Study objective is to assess whether stimulation of the conduction system reduces cardiac decompensation events in patient follow-up, and how applicable this is in clinical practice and also to determine the impact of the studied interventions in terms of quality of life and cost-effectiveness for the treatment of patients with atrioventricular block. 1260 adult patients who are candidates for pacemaker implantation for the treatment of atrioventricular conduction disease will be randomised to stimulation of the conduction system or to the conventional stimulation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients with AV block in either sinus rhythm (SR) or permanent atrial tachycardia/atrial fibrillation (AT/AF), or with slow AV conduction during AT/AF, or undergoing AV node ablation + ventricular stimulation
male and female
acquired informed consent
Disqualifiers
Class I indication to Implantable Cardioverter Defibrillator (ICD) or to Cardiac Resynchronization Therapy (CRT)
Ejection Fraction < 35%
Life expectancy < 2 years
Participation in another clinical trial which might impact on the study outcome
Trial design
Parallel
Treatments tested in this trial
Conduction System Pacing (CSP)
Procedure/SurgeryCSP occurs at the left endocardic surface of the interventricular septum hence specifically designed delivery catheters are used to advance the ventricular lead across the septum until its left-sided edge, where the Left Bundle is located. To determine whether CSP has been achieved, a standard 12-lead electrocardiogram (ECG) is continuously recorded.
Right Ventricular (RV) Pacing
Procedure/SurgeryRV pacing delivered either at the RV apex or RV septum. RV pacing is delivered by single chamber or dual chamber pacemakers depending on patients' rhythm (sinus or AT/AF) according to well-established clinical practice as described in the EHRA recommendtions
Treatment groups
Trial outcomes
Primary outcomes
Heart failure
composite endponit of: number of HF events, HF hospitalizations and HF non-pharmacological interventions
Secondary outcomes
number of HF events
number of HF events
HF hospitalizations
HF hospitalizations
HF non-pharmacological interventions
HF non-pharmacological interventions
Sponsors and contacts
Click on the lead sponsor to view all of their trials.